MedicaidPrior AuthHigh impact
Multiplex Pathogen Identification Panels for Infectious Disease - MEDICAID - KENTUCKY (Revised)
Humana·KY · Infectious Disease, Internal Medicine, Emergency Medicine +5 more·Medicaid
Effective date
Jun 29, 2026
We identified it
Jun 26, 2026
Summary
Humana Kentucky Medicaid revised its multiplex pathogen identification panel policy effective 06/29/2026, establishing new coverage criteria for infectious disease testing including respiratory panels, vaginal bacterial vaginosis tests, tropical fever panels, and cell-free DNA metagenomic sequencing. Prior authorization is now required for BD MAX Vaginal Panel (81514), Karius Test (0152U), and Bridge Women's Health Infectious Disease Detection Test (0330U). Several tests including NeXGen Fungal/AFB NGS (0531U), Johns Hopkins Metagenomic NGS (0323U), BIOTIA-ID Urine NGS (0590U), and Taq Array Card UTI Panel (0593U) are explicitly non-covered.
Action Required
By 06/29/2026, the billing team must: (1) Update billing software to require prior authorization for CPT 81514 (BD MAX Vaginal Panel), 81515 (Xpert Xpress MVP), CPT 0330U (Bridge Women's Health test), and CPT 0152U (Karius test) for all Humana Healthy Horizons Kentucky Medicaid members; (2) Configure system to deny or reject claims for non-covered codes 0531U, 0323U, 0590U, and 0593U with explanation of benefits stating insufficient evidence; (3) Create internal guidance document for providers listing covered respiratory panels (87632, 87633, 0528U, 0202U, 0563U, 0564U, 0115U, 0225U, 0556U, 0223U) and coverage criteria requiring documented immunocompromised status or high-risk factors; (4) Update encounter forms and templates to include pre-visit planning for infectious disease testing to ensure prior authorization requests are submitted with appropriate clinical documentation; (5) Train billing and authorization staff on new medical necessity criteria for respiratory panels (6+ pathogen targets require negative targeted panel result first) and tropical fever panel (exposure history required); (6) Add validation logic to flag claims for patients under age 21 for EPSDT review. Failure to obtain prior authorization for specified codes will result in claim denials. Non-covered tests submitted will be rejected.